|
Status |
Public on Oct 14, 2022 |
Title |
A Potential Diagnostic Biomarker in Pulmonary Hypertension |
Organism |
Rattus norvegicus |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Right heart failure results from advanced pulmonary hypertension (PH) and has a poor prognosis. There are few available treatments for right heart failure. Pulmonary artery remodeling, including changes in pulmonary artery endothelial cells to endothelial-mesenchymal cells, and aberrant fibroblast and pulmonary artery smooth muscle cell (PASMC) proliferation, are characteristics of the pathophysiological process of PH. As a result, the clinical situation requires novel PH diagnostic and treatment targets.
|
|
|
Overall design |
Monocrotaline was used to create an animal model of PH, and lung tissue was removed for transcriptome sequencing. The targets with the highest differences were chosen for transfection after possible targets were identified using bioinformatic techniques and confirmed by qPCR to examine their function in hypoxic PASMCs.
|
|
|
Citation missing |
Has this study been published? Please login to update or notify GEO. |
BioProject |
PRJNA885779 |
Submission date |
Oct 12, 2022 |
Last update date |
Oct 18, 2022 |
Contact name |
Ke Gong |
E-mail(s) |
xzwkgongke@csu.edu.cn
|
Organization name |
The Second Xiangya Hospital of Central South University
|
Department |
cardiovascular surgery
|
Street address |
139 Renmin Middle road
|
City |
ChangSha |
ZIP/Postal code |
410011 |
Country |
China |
|
|
Platforms (1) |
GPL25947 |
Illumina NovaSeq 6000 (Rattus norvegicus) |
|
Samples (8)
|
|